Trials / Recruiting
RecruitingNCT03249519
Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer
Multimodal Therapy of Advanced Cervical Cancer With Radiotherapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 999 (estimated)
- Sponsor
- University of Erlangen-Nürnberg Medical School · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The combination of radiation therapy or chemoradiation with Interstitial brachytherapy for advanced cervical cancer (pN+, FIGO-Stage II B - IV A is standard of therapy. The radio- and chemosensitive effect of an additional hyperthermia might improve the clinical outcome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radiation | 50.4 Gy |
| RADIATION | brachytherapy | 35-40 Gy |
| DRUG | Cisplatin | weekly 40 mg/m\^2 (6cycles) |
| OTHER | Hyperthermia | 10 times |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2094-12-31
- Completion
- 2099-12-31
- First posted
- 2017-08-15
- Last updated
- 2017-08-15
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03249519. Inclusion in this directory is not an endorsement.